Conditionally immortalized mouse hepatocytes for use in liver gene therapy

This publication has 15 references indexed in Scilit:

• Long-term amerlioration of bilirubin glucuronidation defect in gunn rats by transplanting genetically modified immortalized autologous hepatocytes
  Cell Transplantation, 1998
• Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte Transplantation
  New England Journal of Medicine, 1998
• Early primary biliary cirrhosis: Just delayed or different?
  Hepatology, 1997
• Identification of bipotential progenitor cells in human liver development
  Hepatology, 1996
• Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia
  Nature Genetics, 1994
• Studies on the Safety of Intrasplenic Hepatocyte Transplantation: Relevance toEx VivoGene Therapy and Liver Repopulation in Acute Hepatic Failure
  Human Gene Therapy, 1993
• Hepatocyte cell lines established from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene
  Experimental Cell Research, 1991
• Permanent engraftment and function of hepatocytes delivered to the liver: Implications for gene therapy and Liver Repopulation
  Hepatology, 1991
• Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse.
  Proceedings of the National Academy of Sciences, 1991
• Conditional enhancement of liver-specific gene transcription.
  Proceedings of the National Academy of Sciences, 1988